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Summary: Fifty drugs, applied in the therapy of internal diseases, were investigated for their effect on the clinical
chemical determination of serum glucose by the automated GOD-Perid method. The results showed a statistically
significant depression of the reported glucose value, by 7 drugs containing the pyrazolone group and its derivates
(Baralgin, Butazolidine, Analgin, Novalgetol, Analgocain, Irgapyrin, Aminopyrin) P < 0.001; P < 0.01. The influence
depends on the quantity of drug and on the time interval between loading and glucose analysis.
Einfluß von Arzneimitteln auf klinisch-chemische Serumglucose-Ergebnisse,
untersucht mit der automatisierten GOD-Perid Methode
Zusammenfassung: Es wurde der Einfluß von 50 Arzneimitteln, welche in der Therapie innerer Krankheiten Anwen-
dung finden, auf klinisch-chemische Ergebnisse für Serumglucose, erhalten mit der automatisierten GOD-Perid
Methode, geprüft. Die Ergebnisse zeigen einen statistisch signifikanten (P < 0,001; P < 0,01) erniedrigenden Ein-
fluß von 7 Arzneimitteln, welche die Pyrazolongruppe und deren Derivate enthalten (Baralgin, Butazolidin, Analgin,
Novalgetol, Analgocain, Irgapyrin, Aminopyrin) auf die Glucosewerte. Der Einfluß ist von der Arzneimittelmenge
sowie vom Zeitintervall zwischen Applikation und Glucoseanalyse abhängig.
Introduction
Clinical chemical data for blood glucose, determined
with specific glucose-oxidase reactions, are influenced
by ascorbic acid (1, 2), hydrogen-peroxide and hypo-
chlorite (3), diuretics and some other drugs (4). The
interference of the sulphonylureä drugs, Tolazamide
and Tolbutamide, in the determination of glucose by
the GOD-Perid method has been described (5,6), and
it is a consequence of the lack of specificity of the
final chromogen color reaction of this analytical proce-
dure. Reducing substances either compete with the
chromogen for H^C^ or keep it in reduced state leading
to low glucose values (6). With regard to published data
(1—6) and to our observation on the serum gjucose
depressing effect of Baralgin, the aim of this work was
to investigate drugs, applied in the therapy of internal
diseases, for their possible influence on serum glucose
data, estimated with the GOD-Perid method. Simultane*
ously the influence of drugs on serum urea data was
investigated.
Material and Methods
The analyses were performed in clear, nonhemolyzed, fasting
sera and in glucose water solutions before and after in vitro
loading with each of the 50 drugs listed in table 1.
Most of the investigated drugs were in solution for intravenous
application, except the oral tablet drugs Tolbusal, Meldian,
Buformin, Daonil and Thyralette. The loading of sera and
glucose solution 5.55 mmol/1 (100 mg/dl) was performed by
dilution of the ampule contents with serum in the proportions
found in 3000 ml plasma 3 min after intravenous application,
or by suspending 1 pulverized tablet in 3000 ml serum.
Parallel analyses of glucose in unloaded and drug-loaded material
were performed on the Autoanalyzer I Technicon with the GOD-
Perid ABTS test1), where in the final colorimetric reaction the
redox chromogen indicator ABTS (2,2'-AzUMMlH3-ethyl-benz-
thiazoline-6-sulphonic acid)) (7) is used. To investigate the
eventual interference of 50 drugs (table 1) on urea results, ana-
logous experiments in sera and urea solution (0.83 mmol/1;
50 mg/dl) were performed. Urea was analyzed by the urease-
hypochlorite procedure2).
1) Blood-Sugar GOD-Perid ABTS Biochemica Test Combination,
Boehiinger, Mannheim, Germany.
2) Urea Biochemica Test Combination, Boehringer, Mannheim,
Germany.
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Insulin, Tolbusal, Meldian, Buformin,
Daonil (INN Insulin, Tolbutamide,
Chloropropamide, Buformin hydro-
chloride, Glibenclamide)
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Vitamin Kl (INN Ascorbic, acid., Thia-




M, Ultracorten, Thyralette (INN Pro-
gesterone, Testosterone, Estradiol ben-
zoate - Testosterone isobutyrate,
Prednisone, Levothyroxine sodium)
Ceporin, Penbritin, Streptomycin, Geo-
mycin, Eritromicin, Garamycin, Kanami-
cin, Kemicetin, Vibramycin (INN
Cefaloridine, Ampicillin, Streptomycin,
Oxytetracycline, Erythromycin, Genta-















methanesulfonate sodium - Lidocaine)
*) World Health Organization
International monitoring of adverse reactions to drugs
Drug Reference List No 13,1975.
Suppl. No 1,2, 3 Ref. No 271, 279, 287,1976.
Experiments and Results
50 drugs were investigated. 7 drugs containing pyrazolone,
pyrazolidiiie, phenazone or butazone and 2 drugs in-

















Fig. 1. Influence of 9 investigated drugs interfering with serum
glucose data, o Sera, · Loaded sera.
For INN see tables 1,2.
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sodium) + 30 mg diethyl-
aminoacet-2,6-o-xylidid
2500 mg nor-aminp- +
phenazonemesilas sodium




2500 mg nor-aminophenazone +
mesilas sodium + 25 mg Üdö-
cain hydrochloride
450 mg l-2 diphenyl^S +
dioxo-4-N buthyl pyrazoh'din
sodium + 450 mg 1-phenyl·
2,3-dimethyl-4-dimethylamino-
pyrazolon + 30 mg diethyl-
amihoacet-2-o-xylidid
300 mg aminophenazone +
J. Clin. Chem. C15n. Biochem. / Vol. 15,1977 / No. 10
Keler-BaSoka and Stojanovski-Bubanj: Influence of drugs on ch'nical chemical data for serum glucose 551
crease in the measured value for serum glucose. Since
Baralgin showed the greatest effect (fig. 1), further ex-
periments were performed with 85 mg Baralgin per
100 ml of serum or glucose solution. Statistical evalua-
tion of 32 serum glucose data before (x ± s = 4.94 ±
1.17 rhmol/1) and 30 min after loading (x ± s = 0.79 ±
0.62 mmol/1) demonstrated a statistically significant
glucose depressing effect of Baralgin of (P < 0.001).
The difference between mean glucose values in un-
loaded and Baralgin-loaded sera was 4.15 mmol/1 glu-
cose.
The difference between mean glucose data for glucose
solutions of 5.55,11.11,16.65, and 22.22 mmol/1
before and after Baralgin-loading was found to be
2.89 mmol/1.
The addition of 10,20, 30,40,50, 60, 70,80, 90,
and 100 mg of Baralgin to 100 ml serum or glucose
solution (5.55 mmol/1) showed a direct relationship ,^,
between the Baralgin concentration and its depressing
influence on the glucose data. Glucose values were
determined in 10 different sera (x = 4.03 mmol/1) imme-
diately, and 30,60, and 120 min after loading with
Baralgin. The glucose data were most depressed imme-
diately after drug addition (x = 1.58 mmol/1); after 30,
60, and 120 min the decrease was 0.58,0.33 and
0.27 mmol/1 glucose, respectively. None of the 50 in-
vestigated drugs affected the urea values in serum or
urea solution.
Discussion
In this work it was showed that 7 drugs, containing
pyrazolone or derivates lead to a decrease in the re-
ported value for serum glucose, investigated with the
GOD-Perid ABTS method. These drugs contain the
hydrazine-N-N-group, which might have an acceptor
function for the oxygen (5) derived from H202 in the
GOD-Perid ABTS analytic procedure, and possibly
inhibit the chromogen ABTS reaction. The effect de-
pends upon the drug concentration in the serum, the
time interval between drug-loading and glucose analysis,
and probably on the type of substituent in the pyra-
zolone. These findings are in accordance with published
data on the glucose depressing effect of drugs with a
hydrazine group in close proximity to benzene nucleus
(5). Some drugs might compete with the chromogen for
H202 or keep it in reduced state, leading to GOD-POD
reactions that are not specific for the glucose determina-
tion (6).
Our findings show that some unpublished pyrazolone
drugs, depress GOD-Perid serum glucose values, and
complete the list of other drugs with a similar effect
described earlier (1—6). The interaction of ascorbic acid,
in amounts greater than 16.6 mg in 100 ml serum, with
glucose data is confirmed in this work, although no inter-
ference by amounts less than 5.0 mg ascorbic acid in
100 ml sera was observed earlier (9).
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